chr8-98123467-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145860.2(POP1):āc.130G>Cā(p.Ala44Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001145860.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POP1 | NM_001145860.2 | c.130G>C | p.Ala44Pro | missense_variant | 2/16 | ENST00000401707.7 | NP_001139332.1 | |
POP1 | NM_001145861.2 | c.130G>C | p.Ala44Pro | missense_variant | 2/16 | NP_001139333.1 | ||
POP1 | NM_015029.3 | c.130G>C | p.Ala44Pro | missense_variant | 2/16 | NP_055844.2 | ||
POP1 | XM_011516801.3 | c.130G>C | p.Ala44Pro | missense_variant | 2/12 | XP_011515103.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POP1 | ENST00000401707.7 | c.130G>C | p.Ala44Pro | missense_variant | 2/16 | 2 | NM_001145860.2 | ENSP00000385787 | P1 | |
POP1 | ENST00000349693.3 | c.130G>C | p.Ala44Pro | missense_variant | 2/16 | 1 | ENSP00000339529 | P1 | ||
POP1 | ENST00000522319.5 | c.130G>C | p.Ala44Pro | missense_variant | 2/5 | 4 | ENSP00000428945 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251338Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135852
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461526Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727068
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74420
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2022 | The c.130G>C (p.A44P) alteration is located in exon 2 (coding exon 1) of the POP1 gene. This alteration results from a G to C substitution at nucleotide position 130, causing the alanine (A) at amino acid position 44 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 27, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with POP1-related conditions. This variant is present in population databases (rs201751827, gnomAD 0.02%). This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 44 of the POP1 protein (p.Ala44Pro). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at